| 2024-08-28 |
详情>>
股本变动：
变动后总股本175.00万股
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益15.86美元,归母净利润1941.21万美元,同比去年增长831.75%
|
| 2024-07-26 |
复牌提示：
2024-07-26 07:55:00 停牌，复牌日期 2024-07-26 08:30:00
|
| 2024-06-26 |
详情>>
业绩披露：
2024年一季报每股收益20.49美元,归母净利润2124.60万美元,同比去年增长3233.85%
|
| 2024-04-22 |
详情>>
业绩披露：
2023年年报每股收益-23.35美元,归母净利润-1784.36万美元,同比去年增长-413.91%
|
| 2024-01-16 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-8.65美元,归母净利润-612.76万美元,同比去年增长-140.59%
|
| 2023-08-18 |
详情>>
业绩披露：
2023年中报每股收益-3.93美元,归母净利润-265.28万美元,同比去年增长-29.79%
|
| 2023-08-14 |
财报披露：
美东时间 2023-08-14 盘后发布财报
|
| 2023-06-22 |
详情>>
拆分方案：
每15.0000合并分成1.0000股
|
| 2023-05-25 |
股东大会：
将于2023-06-15召开股东大会
会议内容 ▼▲
- 1.To approve a proposal to authorize our board of directors (the “Board”), in its sole and absolute discretion, and without further action of the stockholders, to file an amendment to our Second Amended and Restated Certificate of Incorporation, as amended to the date of this proxy statement (the “Certificate of Incorporation”), to effect a reverse stock split of our issued and outstanding common stock, par value $0.00001 per share, at a ratio to be determined by the Board, ranging from one-for-ten to one-for-one hundred (the “Reverse Split”), with the Reverse Split to be effected at such time and date, if at all, as determined by the Board in its sole discretion, but no later than December 31, 2023, when the authority granted in this proposal to implement the Reverse Split would terminate (Proposal 1);
2.To approve an amendment to the Company’s Second Amended and Restated 2019 Equity Incentive Plan (“2019 Equity Incentive Plan”) to increase the number of shares reserved for issuance thereunder by 2,000,000 shares (Proposal 2);
3.To elect five directors to the Board each to serve a term of one year and until their respective successors have been elected and qualified, or until their earlier resignation or removal. The Board intends to present for election the following five nominees: Suren Ajjarapu, Prashant Patel, Donald G. Fell, Michael L. Peterson, and Jeff Newell (Proposal 3);
4.To ratify the appointment of MaloneBailey LLP as our independent auditor for the fiscal year ending December 31, 2023 (Proposal 4);
5.To approve an adjournment of the Annual Meeting, if necessary and appropriate, as determined by the Board in its sole discretion, to solicit additional proxies if there are insufficient votes at the time of the Annual Meeting to approve the presented proposals or to constitute a quorum (Proposal 5);
6.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-05-15 |
详情>>
业绩披露：
2023年一季报每股收益-0.07美元,归母净利润-67.8万美元,同比去年增长29.39%
|
| 2023-03-27 |
详情>>
业绩披露：
2022年年报每股收益-0.41美元,归母净利润-347.21万美元,同比去年增长34.68%
|
| 2022-11-09 |
股东大会：
将于2022-12-20召开股东大会
会议内容 ▼▲
- 1.To approve the issuance of 2,663,045 shares of our common stock issuable upon the exercise of a Common Stock Purchase Warrant dated October 7, 2022 (the “Private Placement Warrants”), in accordance with Nasdaq Listing Rule 5635(d) (the “Warrant Share Issuance Proposal”);
2.To approve an adjournment of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the proposal above (the “Adjournment Proposal”).
|
| 2022-11-07 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-0.31美元,归母净利润-254.69万美元,同比去年增长43.80%
|
| 2022-07-25 |
详情>>
业绩披露：
2022年中报每股收益-0.25美元,归母净利润-204.39万美元,同比去年增长36.72%
|
| 2022-05-09 |
详情>>
业绩披露：
2022年一季报每股收益-0.12美元,归母净利润-96.01万美元,同比去年增长-47.37%
|
| 2022-04-21 |
股东大会：
将于2022-06-02召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Board of Directors (the “Board”) each to serve a term of one year and until their respective successors have been elected and qualified, or until their earlier resignation or removal. The Board intends to present for election the following five nominees: Suren Ajjarapu, Prashant Patel, Donald G. Fell, Charles L Pope, and Christine L Jennings.
2.To ratify the appointment of MaloneBailey, LLP, as the Company’s independent auditors for the fiscal year ending December 31, 2022. The Board of Directors recommends that you approve and ratify the appointment of MaloneBailey, LLP, as the Company’s independent auditors for the fiscal year ending December 31, 2022.
3.To consider a non-binding advisory vote on compensation of our named executive officers. The Board of Directors recommends that you approve and ratify the compensation of our named executive officers.
4.To transact such other business as may properly come before the annual meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-16 |
股东大会：
将于2021-05-27召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Board of Directors (the “Board”) each to serve a term of one year and until their respective successors have been elected and qualified, or until their earlier resignation or removal. The Board intends to present for election the following five nominees: Suren Ajjarapu, Prashant Patel, Donald G. Fell, Charles L. Pope, and Christine L. Jennings.
2.To approve an amendment to our Second Amended and Restated Certificate of Incorporation to change our corporate name from “Trxade Group, Inc” to “TRxADE HEALTH, INC.” The Board of Directors recommends that you approve and ratify the filing of a Certificate of Amendment to our Second Amended and Restated Certificate of Incorporation to change our corporate name from “Trxade Group, Inc.” to “TRxADE HEALTH, INC.”
3.Approve and Ratify the Company’s Second Amended and Restated 2019 Equity Incentive Plan. The Board of Directors recommends that you approve and ratify the Company’s Second Amended and Restated 2019 Equity Incentive Plan which amends the current Amended and Restated 2019 Equity Incentive Plan to (a) clarify that the plan includes a limitation on the number of shares of common stock that may be issued pursuant to the plan; (b) include a 25 million share limit on the number of shares of common stock issuable upon exercise of incentive stock options granted under the plan; and (c) make certain other conforming changes to the plan.
4.To ratify the appointment of MaloneBailey, LLP, as the Company’s independent auditors for the fiscal year ending December 31, 2021. The Board of Directors recommends that you approve and ratify the appointment of MaloneBailey, LLP, as the Company’s independent auditors for the fiscal year ending December 31, 2021.
5.To transact such other business as may properly come before the annual meeting.
|
| 2020-04-16 |
股东大会：
将于2020-05-29召开股东大会
会议内容 ▼▲
- 1.To elect five directors to the Board of Directors (the “Board”) each to serve a term of one year and until their respective successors have been elected and qualified, or until their earlier resignation or removal. The Board intends to present for election the following five nominees: Suren Ajjarapu, Prashant Patel, Donald G. Fell, Michael L. Peterson, and Dr. Pamela Tenaerts.
2.Approve and Ratify the Company’s Amended and Restated 2019 Equity Incentive Plan. The Board of Directors recommends that you approve and ratify the Company’s Amended and Restated 2019 Equity Incentive Plan which amends the current 2019 Equity Incentive Plan to (a) increase by one million, the number of shares reserved for issuance under such plan; and (b) to amend such plan to include an ‘evergreen’ feature, which will automatically increase the number of shares available for awards on an annual basis.
3.To ratify the appointment of MaloneBailey, LLP, as the Company’s independent auditors for the fiscal year ending December 31, 2020. The Board of Directors recommends that you approve and ratify the appointment of MaloneBailey, LLP, as the Company’s independent auditors for the fiscal year ending December 31, 2020.
4.To transact such other business as may properly come before the annual meeting.
|
| 2020-04-14 |
详情>>
内部人交易：
Doss Howard A.等共交易7笔
|